AHCO vs. RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, WGS, VCYT, and ARDT
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), GeneDx (WGS), Veracyte (VCYT), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.
AdaptHealth vs. Its Competitors
AdaptHealth (NASDAQ:AHCO) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, community ranking, dividends, profitability, analyst recommendations, institutional ownership and valuation.
RadNet has a net margin of -0.25% compared to AdaptHealth's net margin of -6.57%. AdaptHealth's return on equity of 9.62% beat RadNet's return on equity.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 1.6% of AdaptHealth shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
AdaptHealth presently has a consensus price target of $13.40, suggesting a potential upside of 53.14%. RadNet has a consensus price target of $69.75, suggesting a potential upside of 20.53%. Given AdaptHealth's higher possible upside, research analysts clearly believe AdaptHealth is more favorable than RadNet.
In the previous week, RadNet had 1 more articles in the media than AdaptHealth. MarketBeat recorded 7 mentions for RadNet and 6 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.52 beat RadNet's score of 1.32 indicating that AdaptHealth is being referred to more favorably in the media.
RadNet has lower revenue, but higher earnings than AdaptHealth. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
AdaptHealth has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500.
RadNet received 266 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.05% of users gave RadNet an outperform vote while only 62.94% of users gave AdaptHealth an outperform vote.
Summary
AdaptHealth beats RadNet on 10 of the 19 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
This page (NASDAQ:AHCO) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy AHCO Stock Free AHCO Stock Alerts